Modafinil

莫达非尼

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameModafinil
Drug Alias Namemodafinilo莫达芬尼modafinilum莫待芬宁modafinil +[20] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsCNS Embryonal TumorSolid tumoursStress Disorders, Post-Traumatic +[38] 
Global Approved IndicationsSleepinessDisorders of Excessive SomnolenceSleep Apnea, Obstructive
Approved Indications in ChinaSleep Apnea, Obstructive
Original Approved Country/TerritoryN/A
Original Approved Date1994/01/01
Country/TerritoryCanadaUnited StatesGermany +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterGenuine Research Center, EgyptUniversity Of Minnesota +[9] 
Inactive CompaniesThe Brigham and Women's HospitalMylan Pharmaceuticals IncUniversity Of Rochester +[26] 
Active IndicationsCognitionCocaine-Related DisordersSleepiness +[14] 
Inactive IndicationsCNS Embryonal TumorSolid tumoursStress Disorders, Post-Traumatic +[24] 

Other Information

ATC CodeN06BA07
Related LinksWikipediaDrugBankKEGG